While lecanemab is approved for use in USA, Japan, China, South Korea and Israel, the European Medicines Agency (EMA) refused ...

POTOMAC, MD / ACCESSWIRE / October 17, 2024 / IGC Pharma, Inc (NYSE American:IGC) ("IGC" or the "Company"), today announced enrollment of patients at the Baycrest Academy for Research and Education in ...

A recent study suggests that a drug approved for the treatment of seizures may also help treat Alzheimer's in people who do ...

Recent research is looking at the way in which cardiovascular issue may play into the development of dementia, with one study ...

Alzamend Neuro, Inc. (Nasdaq: ALZN) (“ Alzamend ”), a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer’s disease (“ Alzheimer’s ”), bipolar ...

By obtaining high-resolution images of Alzheimer’s disease-affected brain cells as the condition progresses, researchers have identified the specific neurons that are damaged. The information the ...

A leading dementia expert has expressed optimism that a cure for Alzheimer's disease will be discovered within the next decade. Professor Craig Ritchie also predicts that significant advancements in ...

A much-anticipated drug that holds the promise of delaying symptoms of Alzheimer’s disease will not be available in Australia ...

Bipolar disorder has potential links to memory changes during and after depressive or manic episodes. Learn how states and ...

Heparin treatment was associated with a delayed diagnosis of Alzheimer's dementia, electronic health records in two U.S.

For decades, Alzheimer's research has focused on examining amyloid plaques in the brain and prescribing antibody therapeutics that remove the plaques to slow cognitive decline in patients.

Professor Craig Ritchie also believes things will move so quickly that advanced cases of dementia in the future could almost ...